Tag: JPIAMR

Design contest for first global Antibiotic Resistance Symbol

Anders BjersNews and press

A design contest to find the first global Antibiotic Resistance symbol has been launched today by the European Union Joint Action on Antimicrobial Resistance and Healthcare-Associated Infections (EU-JAMRAI). The contest is not about creating another logo, it should be something tangible that can be crafted by anyone and worn by everyone; like the AIDS ribbon. Be a changemaker and take part in the contest or encourage the public to participate!

Read more on the contest at the EU-JAMRAI website (link, opens in a new window)

Read the EU-JAMRAI press release (pdf, opens in a new window)

JPIAMR in first SEDRIC Global Meeting

Anders BjersNews and press

JPIAMR participated in the first SEDRIC Global Meeting on the 9th of October 2019 in London. The title of the meeting was ‘Mobilising epidemiology and surveillance data to inform patient care pathways”. JPIAMRs Laura Marin was one of the panellists on the ‘International Activities’ session. The session was a roundtable discussion on the topic ‘mobilising surveillance and epidemiology data to inform patient care pathways’. The panel also had participants from WHO, CDC and Fleming Fund on international AMR surveillance efforts.

JPIAMR supports ten networks in the area of one health surveillance.

AMR top priority in European Council Conclusions

Anders BjersNews and press

We want to highlight this summers EU Council Conclusions (through the EU Ministers of Health) that reaffirms the challenge of AMR as a top priority for the EU. The Conclusions indicate that EU Member States should be supported in their efforts to combat AMR, but they also need to do more at national level. The Council agrees that the European Commission and EU Member States should further support JPIAMR efforts:

“The Council notes with great concern the market failure in antibiotic development and underlines the need for urgent action to stimulate the development of new antimicrobials, alternative therapies and rapid and modern diagnostics, including methods for antimicrobial susceptibility testing. EU and global coordination and cooperation on research programmes and incentives are needed, and the Council recognises, inter alia, the proposals and activities of the ‘Antimicrobial Resistance Review team’, the ‘Breaking Through the Wall’ report and the ‘Joint Programming Initiative on Antimicrobial Resistance’.” (see p.8)

“Calls upon Member States and the Commission to: Boost research, development and innovation related to AMR, and support EU and global coordination and cooperation including activities through the Joint Programming Initiative on Antimicrobial Resistance and the Global AMR R&D Hub. (see p. 12)”

Please find the full Conclusions here.

Report: Regional AMR Workshop in Latin America

Anders BjersNews and press

On June 5-7, 2019, the regional JPIAMR workshop Experiences and Areas of Interest for Strengthening Antimicrobial Resistance Networks was held at the Science Cultural Centre in Buenos Aires, Argentina. The workshop had excellent results in terms of attendance, subjects covered and impact on national, regional and global AMR networks and groups.

Next steps and activities:

  • Information sessions (INFODAYS) will be held throughout the year for researchers and other stakeholders about JPIAMR and H2020 calls on this subject that are open to third countries.
  • In line with the conversations held between producers and other AMR players, further joint meetings and activities will be held to identify the problems faced by everyone on this issue.
  • Participation in all AMR dissemination and awareness activities through the available internal and external channels. Likewise, world awareness days, such as the World Microbiome Day on 27 June, will be taken advantage of by publishing posts and articles on AMR.
  • Joint activities with other areas of government will be planned, to present AMR efforts in dissemination fairs with great geographic coverage, such as TECNÓPOLIS and TECNÓPOLIS FEDERAL, and other activities achieved through the Linkage area.

Download the full report: Regional Seminar Report – Experiences and Areas of Interest for Strengthening Antimicrobial Resistance Networks (pdf, 1 MB, opens in a new window).

Come see JPIAMR at FEMS 2019

Anders BjersNews and press

Members of JPIAMR will attend FEMS 2019 from July 7-11 in Glasgow, Scotland. If attending as well, please stop by our poster on the JPIAMR Virtual Research Institute.

This poster describes how JPIAMR uses the Strategic Research and Innovation agenda to outline different joint actions, with a focus on the JPIAMR- Virtual Research Institute. Come and talk to us to find out more!

When: Tuesday July 9; 17.00-19.00

Poster Session: Education / Professional Development / Policies

Poster number: PT138

EU Commissioner urges countries to join JPIAMR

Anders BjersNews and press

In a speech on June 20, at the Second Ministerial Conference on Antimicrobial Resistance in The Netherlands, Vytenis Andriukaitis, the Commissioner for Health and Food Safety, reaffirmed his positive view of JPIAMR by saying: “Collaboration is an essential part of any successful research programme. So, I am particularly proud of the Joint Programming Initiative on antimicrobial resistance, which pools the national research efforts of 27 countries on 5 continents and covers the full One Health spectrum.”

Also, in his speech, Commissioner Andriukaitis urged Ministers present and their countries to join JPIAMR: ”This Initiative grows stronger with every new member, so we need more countries and more investment. The Virtual Research Institute under the Joint Programming Initiative on AMR (JPIAMR) will create a platform to increase coordination, improve visibility, and facilitate knowledge exchange and capacity development as well as the use of scientific evidence.
Ministers, join us in this work!”

JPIAMR at the Second Ministerial Conference on AMR

Anders BjersNews and press

On 19-20 June 2019, JPIAMR will participate in the Second Ministerial Conference on Antimicrobial Resistance, Accelerating Ambitions for Future Health in Noordwijk, The Netherlands. The focus of the conference will be international and multi-sectoral cooperation within the framework of the One Health approach. The program can be seen here.

JPIAMR will take part in a panel discussion in a break-out session entitled Addressing AMR to deliver the SDGs – strengthen knowledge and evidence base and hold an information stand for participants to provide information on the JPIAMR activities.

JPIAMR at Global AMR R&D Hub workshop

Anders BjersNews and press

On May 28 in Geneva, JPIAMR participated at the Global AMR R&D Hub workshop on “AMR R&D investments”. The objective was to identify and discuss opportunities for investments and new and innovative financing mechanisms for AMR R&D using a global One Health approach. It aimed at providing recommendations on how the Global AMR R&D Hub can support those activities. JPIAMR’s Laura Marin presented in one of the sessions about AMR investments and the JPIAMR AMR Research Funding Dashboard.

Download the workshop report (pdf, opens in a new window)

Download the workshop program (pdf, opens in a new window)

Nine New JPIAMR SAB members

Anna SundinNews and press

JPIAMR is pleased to welcome nine new members to the Scientific Advisory Board, SAB. The new members have diverse experience in the field of AMR, adding key knowledge and experiences to the whole SAB. Now fifthteen members strong.

The following SAB members have been appointed by the JPIAMR Management Board for the period 2019-2021:

  • Till Bachmann, UK
  • Rafael Cantón, Spain
  • Ramanan Laxminarayan, USA and India
  • Marc Lemonnier, France
  • Luísa Vieira Peixe, Portugal
  • Anngret Schneider, Germany
  • Constance Schultsz, Netherlands
  • Ed Topp, Canada
  • Jordi Vila, Spain

For individual biographies and further information, please click here.

Kick-off: ECRAID, the European Clinical Research Alliance on Infectious Diseases

Anders BjersNews and press

JPIAMR will be participating in a high-level meeting in Brussels, on January 17th 2019, on the development of ECRAID, the European Clinical Research Alliance on Infectious Diseases. ECRAID envisages a European-wide sustainable clinical research organization for infectious diseases and AMR, antimicrobial resistance. Laura Marin, JPIAMR Head of Secretariat, will participate in panels, etc.

ECRAID’s vision is to create a coordinated and permanent European clinical research infrastructure for clinical research on infectious diseases.  The focus is on two major challenges: emerging infectious diseases with epidemic or pandemic potential, caused by new or re-emerging pathogens, and AMR (antimicrobial resistance). ECRAID will be enable clinical research to be faster and easier having rapid access to and knowledge of developed clinical and laboratory sites. Trials will be conducted continuously to expand on knowledge and experience.

The organisations aim is to protect public health by generating evidence in order to improve diagnosis, prevention, and treatment.  The ECRAID mission is to facilitate and develop world class research to protect citizens of Europe against AMR (antimicrobial resistance) and infectious diseases, over the long term. Professor Herman Goossens together with epidemiologist Marc Bonten, is the project coordinators of ECRAID.

There will be panel discussions with clinical research networks, preclinical research networks, pharmaceutical and diagnostic companies,
SMEs, etc. Together with speakers such as EU Commissioner Carlos Moedas, Herman Goossens, Marc Bonten, Magda Chlebus, Executive Director, Science Policy & Regulatory Affairs, EFPIA and Jeremy Farrar, Director of the Wellcome Trust, and others. This is a closed meeting.